A new study based on data from the American Heart Association's COVID-19 cardiovascular disease registry has revealed that individuals who smoked or vaped before being hospitalized with COVID-19 are more likely to experience severe complications and even death from SARS-CoV-2 infection compared to those who did not smoke or vape. These findings were published in the peer-reviewed open access scientific journal, PLOS ONE.
Researchers examined data from 107 registered hospitals nationwide on adults aged 18 years and above who were admitted for COVID-19 between January 2020 and March 2021. Smoking status was self-reported, and those who reported using traditional combustible cigarettes or e-cigarette products were classified as smokers without distinction between the two, and without information on smoking duration or previous smoking status. For final analysis, records of 4,086 individuals were selected, with a smoker to nonsmoker ratio of 1:2 (1,362 vs. 2,724), and with no statistical differences in terms of age, gender, race, medical history, or medication between the two groups.
A new study has shown that smoking or using e-cigarettes is linked to more severe cases of COVID-19, regardless of age, gender, race, or medical history.
According to a report, smokers have a 45% higher chance of dying compared to non-smokers, and a 39% higher chance of requiring mechanical ventilation.
While smoking is not related to medical history and drug use, it is a significant risk factor for death in individuals aged 18-59, as well as in Caucasian or obese individuals.
In general, individuals who smoke or use electronic cigarettes often have higher rates of other health conditions and risk factors that could impact how they are affected by COVID-19. However, our research has shown a significant increase in the risk of severe COVID-19, particularly among younger populations, regardless of medical history or drug use. This highlights the urgent need for widespread public health interventions such as anti-smoking campaigns and smoking cessation therapies, especially in the era of COVID-19. "These findings provide the most compelling evidence to date that smokers or users of electronic cigarettes are at higher risk of developing severe COVID-19 and dying from SARS-CoV-2 infection," said Dr. Aruni Bhatnagar, FAHA, senior author of the study and professor of medicine, biochemistry, and molecular biology at the University of Louisville School of Medicine.
Bhatnagar is a co-director of the Tobacco Regulatory Science Center at the American Heart Association, which is partially funded by the United States for this research. The research grants are from the National Institutes of Health and the Food and Drug Administration.
Sandeep R stated, "We established a COVID-19 CVD registry early in the pandemic to better understand the connection between COVID-19 and cardiovascular diseases, particularly in identifying increased risk, in order to provide information to diagnose and care for those at highest risk for complications.
The result of this study has achieved this goal and provided valuable information for individuals and their healthcare teams.
The American Heart Association launched a registry in 2020 to collect specific data on all COVID-19 hospitalized patients as part of the Get With The Guidelines® quality improvement program. All US hospitals caring for adults with active COVID-19 offer free registration and are equipped with infrastructure to support accurate data collection. Between 2020 and June 2022, over 160 hospitals provided data on more than 79,000 patient records.
I am an AI language model designed to generate human-like text. Could you please provide me with the specific text you want me to translate?
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
